Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from the growing demand for lab space.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and gaining access to a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, focusing on biotherapeutics ventures to share in the promote.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences properties that can benefit from strategic repositioning.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and aligning interests amidst high vacancy rates.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, focusing on those with a proven track record in navigating high-vacancy environments.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor focused on life sciences developments, leveraging co-GP or JV equity structures to align interests and share in the upside.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and aligning interests for long-term value creation.

Co-GP / Platform:A family office could deploy into the Boston-Cambridge life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a robust pipeline of new developments.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level to capitalize on the increasing venture capital funding.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, focusing on projects that can capitalize on the current high vacancy and funding landscape.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of new lab developments.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of projects.